Inari Medical, Inc. Common Stock
NARI
NARI was delisted on the 18th of February, 2025.
99 hedge funds and large institutions have $604M invested in Inari Medical, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 31 closing their positions.
63% more capital invested
Capital invested by funds: $370M → $604M (+$234M)
53% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 17
48% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 31
18% more funds holding
Funds holding: 84 → 99 (+15)
24% less call options, than puts
Call options by funds: $2.42M | Put options by funds: $3.19M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$35.1M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$29.5M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$29.1M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$25.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$34.1M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$14.5M |
| 3 |
VA
VR Adviser
New York
|
-$11.4M |
| 4 |
JIP
Jaffetilchin Investment Partners
Tampa,
Florida
|
-$5.42M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.81M |
NARI Hedge Fund Activity: Q3 2020 in Review
99 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Inari Medical, Inc. Common Stock (NARI) for Q3 2020, worth a combined $604M — up 63% from $370M a quarter earlier.
Buyers outnumbered sellers: 46 funds opened new NARI positions and 31 closed out — a net gain of 15 holders — while 26 added to existing stakes and 17 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $35.1M. The largest seller was Fidelity Investments, cutting an estimated $34.1M.
- 99 institutional investors held Inari Medical, Inc. Common Stock (NARI) as of Q3 2020, up from 84 in Q2 2020.
- Funds reported $604M of Inari Medical, Inc. Common Stock stock for Q3 2020, up 63% quarter-over-quarter.
- 46 funds opened new Inari Medical, Inc. Common Stock positions in Q3 2020 and 31 closed out, a net change of +15 holders.
- The largest Inari Medical, Inc. Common Stock buyer in Q3 2020 was BlackRock, an estimated $35.1M added.
- The largest Inari Medical, Inc. Common Stock seller in Q3 2020 was Fidelity Investments, an estimated $34.1M sold.
Based on aggregated 13F filings for Q3 2020.